As of Mar 27
| +0.53 / +5.24%|
The 4 analysts offering 12-month price forecasts for Corcept Therapeutics Inc have a median target of 10.00, with a high estimate of 18.00 and a low estimate of 5.00. The median estimate represents a -6.10% decrease from the last price of 10.65.
The current consensus among 4 polled investment analysts is to Buy stock in Corcept Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.